Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.> home > News & Announcements > Abgent at the UC San Francisco Parnassus Campus Biotechnology Vendor Showcase™
Abgent at the UC San Francisco Parnassus Campus Biotechnology Vendor Showcase™
Jun 04, 2014
Thursday, June 5th, 2014
10:00 am - 2:30 pm
Millberry Union, Gymnasium
University of California, San Francisco
Abgent, a WuXi AppTec company, is a leading manufacturer of primary antibodies with more than a decade of experience. We strive to meet the ever changing demands of research and drug discovery through a thoughtful target selection process and strengthened validation-standards.
Stop by Abgent table # 29
for special offers on products and services!
Company highlights:
- Most antibodies are produced in-house to ensure product quality and reproducibility.
- Over 1,000 new antibodies are released per year.
- Striving for proteome-wide antibody coverage with a focus on autophagy, stem cells, and neurodegeneration.
- Featuring the Abgent "Crown" line of premium antibodies.
- Evaluation size vials for more than 10,000 products.
Our antibody collection includes:
- Over 18,000 primary antibodies
- Antibodies for most human kinases
- More than 500 phospho-specific antibodies
Events
